|
Grants to private companies to cure neglected diseases
The Government of India may give non-repayable grant-in-aid to the Pharmaceutical companies for developing drugs for neglected tropical diseases like Malaria, Tuberculosis...
Read the
whole article at:
http://economictimes.indiatimes.com/News/News_By_Industry/Govt_plans_grants_to_pvt_cos_to_cure_neglected_diseases/articleshow/2843816.cms
----------------------------------------------------------------------------------------------------------------------------
Rational prescribing will save billions of rupees
Pharmaceutical companies spend billions of dollars annually to ensure that physicians prescribe the most expensive, most promoted drug to the patients.
Read the
whole article at:
http://www.dailymirror.lk/DM_BLOG/Sections/frmNewsDetailView.aspx?ARTID=8474
----------------------------------------------------------------------------------------------------------------------------
Finance Minister asks Pharmaceutical Companies to hold drug prices or lower them
Finance Minister urged the drug manufacturers to put hold on price of the drugs and have advised the companies to expand production so that economy of scale can be reached to gain can be made in terms of volume.
Read the
whole article at:
http://www.business-standard.com/common/news_article.php?autono=315980&leftnm=3&subLeft=0&chkFlg
----------------------------------------------------------------------------------------------------------------------------
Pharma Industry to drive next IT outsourcing wave
The Pharmaceutical industry is expected to be a significant contributor to the third wave of outsourcing, with the US market- worth over $4trn. Pharmaceutical Research, including Clinical Trials will lead the Globalization of Healthcare processes.
Read the
whole article at:
http://www.outsourcing-pharma.com/news/ng.asp?n=83674-tholons-it-outsourcing
----------------------------------------------------------------------------------------------------------------------------
Indian Pharmaceutical Industry poised to take off
The Economic Times Bio-Pharma Development Summit in Mumbai, brought together the top players of the sector and the policy makers on a common platform to look at the current and future industry scenario.
Read the
whole article at:
http://economictimes.indiatimes.com/Healthcare/Indian_pharma_industry_poised_for_take-off/articleshow/2817505.cms
----------------------------------------------------------------------------------------------------------------------------
Gene Therapy Drug
Shows Promise in MS Patients
Palo
Alto, Calif.-based
Bayhill Therapeutics reported positive results from a phase IIb
trial of BHT-3009 for the treatment of multiple sclerosis. BHT-3009
is a gene therapy drug that delivers DNA that instructs cells to
produce myelin basic protein (MBP). Myelin is the phospholipid
sheath that surrounds neurons and is the target of many autoimmune
diseases such as MS.
This
multi-center, randomized, double-blind, placebo-controlled study
enrolled 289 subjects with relapsing, remitting multiple sclerosis.
The subjects received monthly intramuscular injections of BHT-3009
for one year.
----------------------------------------------------------------------------------------------------------------------------
Drug
Regulators to Monitor Side Effects
The Central Drugs Standard Control Organization is now planning to
appoint a team of about 100 clinical pharmacologists across the
country, on a contract basis, to collect adverse drug reaction
reports and patient complaints from hospitals, clinics and
practicing clinicians.
Read the
whole article at:
http://www.livemint.com/2007/08/27004814/Drug-regulator-to-monitor-side.html
----------------------------------------------------------------------------------------------------------------------------
Call for a
change-
Ayurveda
is one of the world's oldest medical sciences. However, even after
five thousand years, it is still struggling to cross borders.
Read the whole article at:
http://www.expresspharmaonline.com/20070915/research01.shtml
----------------------------------------------------------------------------------------------------------------------------
Making drugs safer
India
has become a major hub for clinical trials. However, whether
patients in India receive safe drugs or not is still very much in
question.
Read the whole article at:
http://www.expresspharmaonline.com/20070915/research02.shtml
----------------------------------------------------------------------------------------------------------------------------
India developing regulatory guidelines for nanotechnology drugs
NIPER, the Indian National Institute of Pharmaceutical Education and
Research, is planning to take up the ambitious task of developing
regulatory guidelines for approving nanotechnology based drugs.
Read the whole article at:
http://www.nanowerk.com/news/newsid=1059.php
----------------------------------------------------------------------------------------------------------------------------
Data
Exclusivity: Access to Medicine in Danger
Pharmaceuticals and agrochemicals are two key sectors having direct
implication to the everyday life of the people. Hence, it is
important to regulate the safety, efficacy and quality of
pharmaceutical products and agrochemical products. Most countries in
the world have their own regulations for the marketing of these
products. While patents are meant to reward innovations by giving
the inventor a monopoly right for a fixed term, the regulatory
approval system seeks to ensure that only medicines having safety,
efficacy and quality enter into the market. Often, the national
regulatory authorities would ask the manufacturer itself to provide
relevant information to assess the quality and efficacy of medicines
and pesticides.
To
read the complete article:
http://www.mainstreamweekly.net/article314.html
----------------------------------------------------------------------------------------------------------------------------
India:
Ministries Say Yes To Data Protection
Pursuant to the suggestions made by the inter-ministerial committee
on data protection headed by Satwant Reddy, former chemicals
secretary, the ministries of health and agriculture, in a recent
meeting, decided to initiate action to bring amendments inserting
data protection clauses in the Drugs and Cosmetics Act, 1940 and
Insecticides Act, 1968.
To
read the complete article:
http://www.mondaq.com/article.asp?articleid=52316
----------------------------------------------------------------------------------------------------------------------------
|
